1-Andro Liquid

Product Details: 1-Andro (Liquid)

1-Andro is actually 1-Dehydroepiandrosterone, 1-DHEA. It is a lab-made androgenic compound and is studied in experimental and preclinical models. It comes from a class of steroidal compounds that are structurally related to endogenous androgens. In laboratory settings, it is of interest as a precursor molecule within steroidogenesis pathways.

Its chemical structure makes it a substrate in enzymatic conversion studies. This makes it valuable for research focused on:

• androgen receptor signaling, 
• metabolic pathways, and 
• anabolic regulatory mechanisms in controlled model systems

The compound’s stability and defined molecular profile make it great in biochemical and cellular experiments.

Mechanism of Action

In experimental and preclinical environments, 1-Andro is under focus for its enzymatic conversion into bioactive androgenic metabolites. This becomes possible through 17β-hydroxysteroid dehydrogenase (17β-HSD) activity. This enzymatic process produces metabolites. These include 1-testosterone (dihydroboldenone), which is structurally analogous to endogenous androgens.

These metabolites are examined for their interaction with androgen receptor isoforms. This helps in research into receptor binding affinity, transcriptional activation, and downstream signaling pathways. Additionally, variability among 17β-HSD isoenzymes allows researchers to study differential metabolic pathways and enzyme-specific steroid transformations in laboratory models.

Properties of 1-Andro (Liquid):

• Molecular Formula: C19H28O2
  
• Molecular Weight: 288.43 g/mol
  
• CAS Number: 23633-63-8
  
• PubChem CID: 101850
  
• Synonyms: 1-Andro; 1-Dehydroepiandrosterone; 1-DHEA; δ1-Epiandrosterone; 1-Prasterone; 5α-Androst-1-en-3β-ol-17-one
  
• IUPAC Name: (3R,5S,8R,9S,10R,13S,14S)-3-Hydroxy-10,13-dimethyl-3,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one

Research Applications/Benefits of 1-Andro (Liquid)

Steroidogenesis Pathway Research

1-Andro is used in laboratory studies to investigate enzymatic pathways involved in androgen biosynthesis. This is particularly of interest in the role of 17β-HSD isoenzymes in steroid conversion.

Androgen Receptor Binding Studies

Applied in experimental models to see ligand-receptor interactions, receptor activation, and downstream transcriptional signaling pathways.

Muscle Tissue Modeling in Preclinical Systems

Utilized in controlled research settings to study androgen-mediated protein synthesis signaling and skeletal muscle hypertrophy mechanisms in experimental models.

Endocrine Pathway Interaction Studies

Used to explore interactions between androgenic and estrogenic pathways through enzyme-mediated metabolic processes in laboratory environments.

Enzyme Kinetics and Isozyme Analysis

Serves as a substrate in biochemical research to analyze enzyme specificity, catalytic efficiency, and metabolic variability across experimental systems.

Why Choose BehemothLabz to Buy 1-Andro (Liquid)

BehemothLabz is committed to providing high-purity research compounds manufactured under strict quality control standards. Each batch of 1-Andro is subjected to independent third-party testing to verify identity, purity, and consistency. With a focus on scientific reliability and transparency, BehemothLabz ensures researchers receive dependable compounds suitable for advanced laboratory and preclinical studies.

Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments.

ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

References:

1. Miller WL, Auchus RJ. “The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.” Endocrine Reviews. 2011. https://doi.org/10.1210/er.2010-0013
2. Penning TM. “Molecular endocrinology of hydroxysteroid dehydrogenases.” Endocrine Reviews. 1997. https://doi.org/10.1210/edrv.18.3.0304